Initial Experience with Robotic Sleeve Gastrectomy for Morbid Obesity

2010 ◽  
Vol 21 (8) ◽  
pp. 1172-1179 ◽  
Author(s):  
Theodoros Diamantis ◽  
Andreas Alexandrou ◽  
Nikolaos Nikiteas ◽  
Athanasios Giannopoulos ◽  
Eustathios Papalambros
2009 ◽  
Vol 2 (3) ◽  
pp. 68-72 ◽  
Author(s):  
M Ohta ◽  
S Kai ◽  
Y Iwashita ◽  
Y Endo ◽  
T Hirashita ◽  
...  

2016 ◽  
Vol 14 (2) ◽  
pp. 1-6
Author(s):  
Zafar Gondal ◽  
Ali Yammahi ◽  
Alya Mazrouei ◽  
Faisal Badri ◽  
Juanita Bonilla ◽  
...  

2015 ◽  
Vol 12 (2) ◽  
pp. 283-287 ◽  
Author(s):  
Andreas Alexandrou ◽  
Eleftherios Mantonakis ◽  
Emmanouil Pikoulis ◽  
Theodora Margariti ◽  
Nikos Dimitrokallis ◽  
...  

2010 ◽  
Vol 34 (3) ◽  
pp. 585-589 ◽  
Author(s):  
M. Kelogrigoris ◽  
E. Sotiropoulou ◽  
K. Stathopoulos ◽  
V. Georgiadou ◽  
P. Philippousis ◽  
...  

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 78-OR
Author(s):  
FARHAT FATIMA ◽  
JØRAN HJELMESÆTH ◽  
KARE I. BIRKELAND ◽  
HANNE L. GULSETH ◽  
JENS K. HERTEL ◽  
...  

Author(s):  
Tantawi Abdel Naeem Mohamed ◽  
Salah Abdel- Razik ◽  
Ayman Mohamed Hassanien ◽  
Tohamy A. Tohamy ◽  
Ashraf Abdel Azeem ◽  
...  

2020 ◽  
Vol 13 (12) ◽  
pp. e236202
Author(s):  
Omkaar Jaikaran ◽  
Derek Lim ◽  
Brian Binetti ◽  
Vadim Meytes

Portomesenteric thrombosis is an important but rarely reported complication following bariatric surgery. It has been suggested that the incidence of portal vein thrombosis is directly related to many risk factors inherent in the bariatric population as well as factors related to local and systemic effects of laparoscopic surgery. Possible aetiologies vary from systemic inherited hypercoagulable states to a direct inflammatory reaction of portosystemic vessels. Here we present a case report of a 47-year-old obese women who underwent a robotic sleeve gastrectomy with subsequent development of a main portal vein, complete right intrahepatic portal vein and splenic vein thrombosis ultimately found to have a compound mutation of the methylenetetrahydrofolate reductase C677T and A1298C alleles.


2021 ◽  
Vol 7 (1) ◽  
Author(s):  
Hidetaka Ichikawa ◽  
Hirofumi Imoto ◽  
Naoki Tanaka ◽  
Hiroaki Musha ◽  
Shojiro Sawada ◽  
...  

Abstract Background Bariatric surgery is effective for the treatment of patients with morbid obesity and type 2 diabetes mellitus (T2DM), for body weight loss and glycemic control. However, in Japan, there has been no previous report of the effectiveness bariatric surgery in a case of morbid obesity associated with acute onset type 1 diabetes mellitus (T1DM), in which pancreatic β-cells were destroyed and endogenous insulin was depleted. Case presentation A 36-year-old woman with morbid obesity and T1DM, diagnosed when she was 6 years, was admitted for bariatric surgery. At her first consultation, she had a body weight of 106.7 kg and a body mass index of 42.2 kg/m2. Her HbA1c level was 9.0%, with a required daily insulin dose of 75 units. She underwent laparoscopic sleeve gastrectomy. At 1 year after surgery, her body weight had decreased to 81.0 kg and her body mass index to 32.2 kg/m2. In addition, her daily required dose of insulin had decreased to 24 units, with an improvement in her HbA1c level to 7.7%. Conclusions Although further evidence needs to be accumulated, including long-term outcomes, laparoscopic sleeve gastrectomy may provide an effective treatment for patients with morbid obesity and T1DM for body weight loss, improvement in HbA1c level, and insulin dose reduction.


Sign in / Sign up

Export Citation Format

Share Document